|
05-23-2010, 02:52 AM
|
|||
|
|||
Partial response seen with Lilly melanoma drug
Some patients in a small mid-stage clinical trial had a partial response to treatment with an experimental drug being developed by Eli Lilly and Co for advanced melanoma, the deadliest form of skin cancer, according to a summary of the data.
    
|
 |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Harbor BioSciences ApoptoneŽ For Prostate Cancer Shows A Partial Overall Response | cancerfr | Oral Cancer | 0 | 09-15-2010 08:26 PM |
| Lilly Presents New Data In Advanced Melanoma, A Difficult-To-Treat Cancer That Causes | cancerfr | Melanoma | 0 | 05-23-2010 02:52 AM |
| Lilly Presents New Data in Advanced Melanoma - A Difficult-To-Treat Cancer That Cause | cancerfr | Melanoma | 0 | 05-23-2010 02:52 AM |
| Lilly Presents New Data in Advanced Melanoma - A Difficult-To-Treat Cancer That Cause | cancerfr | Skin Cancer | 0 | 05-23-2010 02:52 AM |
| UPDATE 1-Partial response seen with Lilly melanoma drug | cancerfr | Melanoma | 0 | 05-23-2010 02:52 AM |
Linear Mode
